Citigroup Inc Oncology Institute, Inc. Transaction History
Citigroup Inc
- $150 Billion
- Q1 2024
A detailed history of Citigroup Inc transactions in Oncology Institute, Inc. stock. As of the latest transaction made, Citigroup Inc holds 12,854 shares of TOI stock, worth $6,169. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,854
Previous 498
2481.12%
Holding current value
$6,169
Previous $1,000
1900.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TOI
# of Institutions
47Shares Held
12.5MCall Options Held
0Put Options Held
0-
Deerfield Management Company, L.P. (Series C) New York, NY3.36MShares$1.61 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.78MShares$856,0570.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.73MShares$828,2690.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.19MShares$569,6220.89% of portfolio
-
Triatomic Management LP New York, NY885KShares$424,6502.63% of portfolio
About Oncology Institute, Inc.
- Ticker TOI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 73,495,504
- Market Cap $35.3M
- Description
- The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical tr...